Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$15.41

0.07 (0.46%)

05:05
02/11/19
02/11
05:05
02/11/19
05:05

Bed Bath & Beyond downgraded to Sell from Hold at Loop Capital

Loop Capital analyst Anthony Chukumba downgraded Bed Bath & Beyond to Sell and lowered his price target for the shares to $12 from $13. The retailer closed Friday up 8c to $15.42. The recent rally in the shares as unwarranted as management's "much better-than-expected" fiscal 2019 financial guidance is "unrealistic," Chukumba tells investors in a research note. The analyst sees sales growth and profitability headwinds for Bed Bath and says management has a "poor track record" of meeting consensus expectations. Further, shareholders are unlikely to be "bailed out" by a leveraged buyout or activist investment, contends Chukumba.

BBBY Bed Bath & Beyond
$15.41

0.07 (0.46%)

10/02/18
LOOP
10/02/18
NO CHANGE
Target $15
LOOP
Hold
Bed Bath & Beyond pricing gap with Amazon narrowed in August, says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Hold rating and $15 price target on Bed Bath & Beyond (BBBY), saying his channel checks indicate a further narrowing of the pricing gap with Amazon (AMZN). The analyst notes the gap in August has shrunk to 13.6% on average vs. 16.9% in July, but also warns that given its position as the "most dynamic retailer" in the U.S. in terms of pricing, Amazon can "quickly and easily lower prices if top-line growth underperforms".
11/08/18
SBSH
11/08/18
NO CHANGE
Target $13
SBSH
Sell
Bed Bath & Beyond activist probability low, 'screens well' for LBO, says Citi
Citi analyst Kate McShane reiterated a Sell rating on Bed Bath & Beyond shares, noting that the company has faced and continues to face significant challenges despite having enacted a number of changes in recent years. She views activist involvement or an LBO as a low probability given the number of challenges faced, but added that Bed Bath "has always screened well" as an LBO candidate. In a leveraged buyout scenario, the company could cut the dividend, shut down stores and create a smaller store format as a private company, McShane said.
01/02/19
LOOP
01/02/19
NO CHANGE
Target $12
LOOP
Hold
Loop Capital says Bed Bath Beyond, Amazon price gap widens to historical levels
Loop Capital analyst Anthony Chukumba kept his Hold rating and $12 price target on Bed Bath & Beyond (BBBY), saying his periodic pricing study demonstrated that the gap between the company and Amazon.com (AMZN) has widened back to its "historical level". The analyst sees this as a likely negative for the former, but also notes that that discounting has been a challenge in maintaining its gross margins. Chukumba maintains his forecasts on Bed Bath results ahead of next week's earnings, adding that while its stock trades at a discount to historical average levels, the 6.5-times expected forward earnings multiple is "in line" with other "secularly challenged specialty hardlines retailers."
01/25/19
LOOP
01/25/19
NO CHANGE
Target $13
LOOP
Hold
Bed Bath & Beyond new concept store underwhelming, says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Hold rating and $13 price target on Bed Bath & Beyond, saying his recent visit to the company's new larger next-generation store in Chicago was underwhelming. The analyst continues to question the company's expansion of home furnishings assortment, saying the "treasure hunt merchandise" was also not impressive.

TODAY'S FREE FLY STORIES

STMP

Stamps.com

$198.08

-4.03 (-1.99%)

08:11
02/22/19
02/22
08:11
02/22/19
08:11
Downgrade
Stamps.com rating change  »

Stamps.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KL

Kirkland Lake Gold

$36.03

2.6 (7.78%)

08:11
02/22/19
02/22
08:11
02/22/19
08:11
Downgrade
Kirkland Lake Gold rating change  »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CMRX

Chimerix

$1.92

-0.04 (-2.04%)

08:10
02/22/19
02/22
08:10
02/22/19
08:10
Hot Stocks
Chimerix presents results from Phase 3 SUPPRESS trial »

Chimerix announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDOC

Teladoc

$68.25

-1.25 (-1.80%)

08:09
02/22/19
02/22
08:09
02/22/19
08:09
Recommendations
Teladoc analyst commentary  »

Teladoc view remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CLSH

CLS Holdings

08:08
02/22/19
02/22
08:08
02/22/19
08:08
Initiation
CLS Holdings initiated  »

CLS Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNI

ATN International

$59.50

-15.62 (-20.79%)

08:08
02/22/19
02/22
08:08
02/22/19
08:08
Upgrade
ATN International rating change  »

ATN International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 22

    Mar

  • 28

    Mar

MDRX

Allscripts

$11.93

-0.21 (-1.73%)

08:07
02/22/19
02/22
08:07
02/22/19
08:07
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$35.55

-0.26 (-0.73%)

08:07
02/22/19
02/22
08:07
02/22/19
08:07
Hot Stocks
Veritiv to optimize wide format products business »

Veritiv announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

08:06
02/22/19
02/22
08:06
02/22/19
08:06
Recommendations
Appian analyst commentary  »

Appian getting closer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

K

Kellogg

$58.33

-0.13 (-0.22%)

08:06
02/22/19
02/22
08:06
02/22/19
08:06
Hot Stocks
Kellogg elects Erica Mann, Roderick Gillum to board »

Kellogg announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

SYNL

Synalloy

$12.94

0.11 (0.86%)

08:05
02/22/19
02/22
08:05
02/22/19
08:05
Hot Stocks
Synalloy announces stock repurchase program for up to 850,000 shares »

Synalloy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIDU

Baidu

$171.72

0.64 (0.37%)

08:05
02/22/19
02/22
08:05
02/22/19
08:05
Recommendations
Baidu analyst commentary  »

Baidu price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MYL

Mylan

$31.06

-0.54 (-1.71%)

08:04
02/22/19
02/22
08:04
02/22/19
08:04
Hot Stocks
Mylan announces U.S. launch of generic Suboxone Sublingual Film »

Mylan announced the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OBLN

Obalon Therapeutics

$2.17

0.07 (3.33%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Earnings
Obalon Therapeutics reports Q4 EPS (39c), consensus (36c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

TTD

Trade Desk

$150.18

0.07 (0.05%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

HTH

Hilltop Holdings

$19.63

0.06 (0.31%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Hot Stocks
Hilltop Holdings announces retirement of co-CEO Alan White »

Hilltop Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$78.76

-1.26 (-1.57%)

, VYGR

Voyager Therapeutics

$10.70

-0.19 (-1.74%)

08:02
02/22/19
02/22
08:02
02/22/19
08:02
Hot Stocks
AbbVie, Voyager Therapeutics partner to develop vectorized antibodies »

AbbVie (ABBV) and Voyager…

ABBV

AbbVie

$78.76

-1.26 (-1.57%)

VYGR

Voyager Therapeutics

$10.70

-0.19 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 11

    Mar

  • 18

    May

VNTR

Venator Materials

$6.40

0.115 (1.83%)

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Initiation
Venator Materials initiated  »

Venator Materials resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Recommendations
Kraft Heinz analyst commentary  »

Kraft Heinz price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCS

Marcus

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Recommendations
Marcus analyst commentary  »

Marcus price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

NE

Noble Corp.

$3.12

-0.2 (-6.02%)

08:00
02/22/19
02/22
08:00
02/22/19
08:00
Downgrade
Noble Corp. rating change  »

Noble Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

SO

Southern Company

$50.22

0.48 (0.97%)

07:59
02/22/19
02/22
07:59
02/22/19
07:59
Upgrade
Southern Company rating change  »

Southern Company upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDRX

Allscripts

$11.93

-0.21 (-1.73%)

07:59
02/22/19
02/22
07:59
02/22/19
07:59
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ES

Eversource

$70.50

0.23 (0.33%)

07:58
02/22/19
02/22
07:58
02/22/19
07:58
Downgrade
Eversource rating change  »

Eversource downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

KEYS

Keysight Technologies

$81.74

0.67 (0.83%)

07:56
02/22/19
02/22
07:56
02/22/19
07:56
Recommendations
Keysight Technologies analyst commentary  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.